Spectra of bacterial growth in ulcers
Abstract
Objectives: To study the spectra of bacterial growth in ulcers in patients and to compare the range and efficacy of Povidoneiodine, Nitrofurazone and silver sulphadiazine with Metronidazole with sucralfate as topical agents.
Methods: 100 patients with different types of ulcers with either foul smell or showing response to systemic or local treatment were selected and divided into two groups. Study Group or Group A: 1% Metronidazole gel with sucralfate. Control group or Group B: for burns and scalds silver sulphadiazine, for trophic ulcers nitofurazone (FuracinR )) in remaining types of ulcer/wounds Povidone iodine (BetadineR)) ointment was used. Periodic debridement of ulcer/wound was done in both the groups as per requirement. Other general and specific treatment of the patient with regard of his illness was same in both the groups. Systemic antibiotics were given, bacteriological and clinical assessment was daily done.
Results: 93% of cases in Group A and 42% in Group B showed grade III healing within 35 days. Healing was over all faster in Group C and 95% reached grade III within 35 days. One patient in Group B died after 24 days with no signs of healing and remaining 18 patients were converted to Group C after 45 days of treatment. In Group C one patient absconded with grade II healing.
Conclusion: It was observed that results with topical Metronidazole with sucralfatewere definitely superior as compared to Povidone iodine, Nitrofurazone or Silver sulfadiazine.
Downloads
References
2. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. Br J Dermatol. 1987; 117 (5): 591-7. doi: 10.1111/j.1365-2133.1987. tb 07491.x
3. Rahman GA, Adigun IA, Fadeyi A. Epidemiology, etiology, and treatment of chronic leg ulcer: experience with sixty patients. Ann Afr Med. 2010;9(1):1-4. doi: 10.4103/1596-3519.62615.
4. Phillips TJ. Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol. 1994;102(6):38S-41S. doi:10.1111/1523-1747.ep12388556
5. Fu X, Sheng Z, Cherry GW, Li Q. Epidemiological study of chronic dermal ulcers in China. Wound Repair Regen. 1998 ;6(1):21-7.
6. Jones PH, Willis AT, Ferguson IR. Treatment of anaerobically infected pressure sores with topical metronidazole. The Lancet. 1978; 311(8057):214.doi: https://doi.org/10.1016/S0140-6736(78)90654-2
7. Edwards R, Harding KG. Bacteria and wound healing. CurrOpin Infect Dis. 2004;17(2):91-6.
8. Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009; 49 (10):1541-9. doi: 10.1086/644732.
9. Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol. 2010; 28(5):519-26. doi:10.1016/j.clindermatol.2010.03.009
10. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol. 1989 ;15(11):1188-95.
11. Eaglstein WH, Falanga V. Chronic wounds. Surg Clin North Am. 1997;77(3): 689-700. doi:10.1016/ s0039-6109 (05)70575-2
12. Nygaard K, Bergan T, Bjørneklett A, Høverstad T, Lassen J, Aase S. Topical metronidazole treatment inpouchitis. Scand J Gastroenterol. 1994;29(5):462-7.
13. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol. 2008;58(2):185-206.doi:10.1016/j.jaad. 2007. 08.048.
14. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother. 2005;55(2):143-9. Epub 2005 Jan 13. doi:10.1093/jac/dkh513
15. Kucan JO, Robson MC, Heggers JP, Ko F. Comparison of silver sulfadiazine, povidone-iodine and physiologic saline in the treatment of chronic pressure ulcers. J Am Geriatr Soc. 1981; 29(5):232-5. doi:10. 1111/j. 1532-5415.1981.tb01773.x
16. O'Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess. 2000;4(21):1-237. doi: https://doi.org/10.3310/hta4210
17. Ousey K, McIntosh C. Topical antimicrobial agents for the treatment of chronic wounds. Br J Community Nurs. 2009;14(9): S6, S8, S10 passim. doi:10.12968/ bjcn. 2009.14.Sup4.43909
18. McDonald A, Lesage P. Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med. 2006;9(2):285-95. doi: 10.1089/jpm.2006.9.285
19. Powers JG, Higham C, Broussard K, Phillips TJ. Wound healing and treating wounds: Chronic wound care and management. J Am Acad Dermatol. 2016; 74 (4): 607-25; quiz 625-6. doi: 10.1016/j.jaad. 2015. 08.070.
20. Alvarez OM, Kalinski C, Nusbaum J, Hernandez L, Pappous E, Kyriannis C, et al. Incorporating wound healing strategies to improve palliation (symptom management) in patients with chronic wounds. J Palliat Med. 2007;10(5):1161-89. doi:10.1089/jpm.2007.9909
OAI - Open Archives Initiative
Therapoid
